Sichuan Historical Income Statement

603077 Stock

2.04 0.01 0.49%

Historical analysis of Sichuan Hebang income statement accounts such as Selling General Administrative of 234 M, Total Revenue of 5.1 B or Operating Income of 1.1 B can show how well Sichuan Hebang Biotechnology performed in making a profits. Evaluating Sichuan Hebang income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Sichuan Hebang's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Sichuan Hebang Biote latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sichuan Hebang Biote is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sichuan Hebang Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Sichuan Income Statement Analysis

Sichuan Hebang Biote Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Sichuan Hebang shareholders. The income statement also shows Sichuan investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Sichuan Hebang Income Statement Chart

At present, Sichuan Hebang's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 234 M, whereas Total Revenue is forecasted to decline to about 5.1 B.

Selling General Administrative Total Revenue Net Income

Total Revenue

Total revenue comprises all receipts Sichuan Hebang Biote generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in Sichuan Hebang Biote financial statement analysis. It represents the amount of money remaining after all of Sichuan Hebang Biotechnology operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Most accounts from Sichuan Hebang's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Sichuan Hebang Biote current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Sichuan Hebang Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

	2021	2022	2023	2024 (projected)
Operating Income	3.7B	4.5B	1.5B	1.1B
Total Revenue	9.9B	13.0B	8.8B	5.1B

Operating Income Total Revenue

Sichuan Hebang income statement Correlations

	Selling General Administrative	Total Revenue	Operating Income	Cost Of Revenue	Income Before Tax	Net Income	Income Tax Expense	Gross Profit	Other Operating Expenses	Net Income From Continuing Ops	Ebit	Research Development	Total Operating Expenses	Total Other Income Expense Net	Minority Interest	Tax Provision	Net Interest Income	Interest Income	Ebitda	Reconciled Depreciation
Selling General Administrative		-0.08	-0.34	0.06	-0.36	-0.36	-0.26	-0.27	-0.36	-0.36	-0.28	-0.38	-0.04	-0.08	0.32	-0.33	0.08	-0.12	-0.31	-0.27
Total Revenue	-0.08		0.9	0.97	0.87	0.87	0.74	0.92	0.83	0.87	0.74	0.7	0.96	-0.8	-0.85	0.88	0.64	0.43	0.69	0.79
Operating Income	-0.34	0.9		0.76	0.99	0.99	0.71	0.98	0.77	0.99	0.7	0.69	0.8	-0.59	-0.79	0.98	0.43	0.28	0.67	0.65
Cost Of Revenue	0.06	0.97	0.76		0.72	0.72	0.69	0.8	0.8	0.72	0.71	0.62	0.96	-0.85	-0.81	0.74	0.71	0.47	0.65	0.81
Income Before Tax	-0.36	0.87	0.99	0.72		1.0	0.71	0.97	0.78	0.99	0.7	0.68	0.76	-0.52	-0.76	0.98	0.42	0.3	0.68	0.64
Net Income	-0.36	0.87	0.99	0.72	1.0		0.71	0.97	0.77	0.99	0.7	0.68	0.76	-0.52	-0.76	0.98	0.41	0.29	0.68	0.63
Income Tax Expense	-0.26	0.74	0.71	0.69	0.71	0.71		0.76	0.86	0.75	0.99	0.64	0.82	-0.6	-0.93	0.79	0.88	0.87	0.99	0.87
Gross Profit	-0.27	0.92	0.98	0.8	0.97	0.97	0.76		0.78	0.98	0.75	0.73	0.85	-0.65	-0.83	0.99	0.53	0.37	0.73	0.7
Other Operating Expenses	-0.36	0.83	0.77	0.8	0.78	0.77	0.86	0.78		0.78	0.86	0.69	0.85	-0.62	-0.86	0.8	0.71	0.67	0.85	0.92
Net Income From Continuing Ops	-0.36	0.87	0.99	0.72	0.99	0.99	0.75	0.98	0.78		0.75	0.7	0.78	-0.54	-0.8	1.0	0.47	0.36	0.73	0.66
Ebit	-0.28	0.74	0.7	0.71	0.7	0.7	0.99	0.75	0.86	0.75		0.64	0.82	-0.61	-0.94	0.78	0.87	0.88	0.99	0.88
Research Development	-0.38	0.7	0.69	0.62	0.68	0.68	0.64	0.73	0.69	0.7	0.64		0.73	-0.49	-0.67	0.69	0.56	0.49	0.66	0.81
Total Operating Expenses	-0.04	0.96	0.8	0.96	0.76	0.76	0.82	0.85	0.85	0.78	0.82	0.73		-0.87	-0.9	0.81	0.81	0.61	0.78	0.89
Total Other Income Expense Net	-0.08	-0.8	-0.59	-0.85	-0.52	-0.52	-0.6	-0.65	-0.62	-0.54	-0.61	-0.49	-0.87		0.8	-0.58	-0.68	-0.45	-0.55	-0.69
Minority Interest	0.32	-0.85	-0.79	-0.81	-0.76	-0.76	-0.93	-0.83	-0.86	-0.8	-0.94	-0.67	-0.9	0.8		-0.83	-0.81	-0.73	-0.91	-0.87
Tax Provision	-0.33	0.88	0.98	0.74	0.98	0.98	0.79	0.99	0.8	1.0	0.78	0.69	0.81	-0.58	-0.83		0.51	0.4	0.76	0.68
Net Interest Income	0.08	0.64	0.43	0.71	0.42	0.41	0.88	0.53	0.71	0.47	0.87	0.56	0.81	-0.68	-0.81	0.51		0.92	0.86	0.85
Interest Income	-0.12	0.43	0.28	0.47	0.3	0.29	0.87	0.37	0.67	0.36	0.88	0.49	0.61	-0.45	-0.73	0.4	0.92		0.89	0.8
Ebitda	-0.31	0.69	0.67	0.65	0.68	0.68	0.99	0.73	0.85	0.73	0.99	0.66	0.78	-0.55	-0.91	0.76	0.86	0.89		0.88
Reconciled Depreciation	-0.27	0.79	0.65	0.81	0.64	0.63	0.87	0.7	0.92	0.66	0.88	0.81	0.89	-0.69	-0.87	0.68	0.85	0.8	0.88

Click cells to compare fundamentals

Sichuan Hebang Account Relationship Matchups

Sichuan Hebang income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	57.0M	82.2M	77.8M	51.4M	24.4M	25.8M
Selling General Administrative	349.3M	145.9M	117.7M	126.0M	152.9M	234.0M
Total Revenue	6.0B	5.3B	9.9B	13.0B	8.8B	5.1B
Operating Income	671.2M	530.9M	3.7B	4.5B	1.5B	1.1B
Cost Of Revenue	4.6B	4.3B	5.7B	7.5B	6.8B	3.5B
Income Before Tax	583.8M	15.8M	3.6B	4.5B	1.5B	1.0B
Net Income Applicable To Common Shares	516.9M	40.9M	3.0B	3.8B	4.4B	4.6B
Net Income	516.9M	40.9M	3.0B	3.8B	1.3B	862.7M
Income Tax Expense	77.1M	12.9M	551.9M	668.3M	768.6M	807.0M
Gross Profit	1.4B	988.8M	4.1B	5.6B	2.1B	2.2B
Other Operating Expenses	45.4M	43.9M	89.1M	110.2M	126.7M	63.5M
Net Income From Continuing Ops	506.6M	2.9M	3.0B	3.8B	1.3B	1.2B
Ebit	643.2M	522.5M	3.7B	4.5B	5.2B	5.4B
Research Development	38.3M	39.7M	33.3M	67.9M	47.3M	43.1M
Total Operating Expenses	5.3B	4.7B	6.2B	8.5B	7.3B	5.8B
Minority Interest	219.5M	165.7M	(8.0M)	(3.4M)	4.5M	4.3M
Tax Provision	77.1M	12.9M	551.9M	668.3M	257.3M	250.8M
Net Interest Income	(56.7M)	(88.0M)	(69.7M)	(29.3M)	34.4M	36.1M
Interest Income	6.9M	3.7M	9.4M	22.7M	60.4M	63.4M
Ebitda	1.3B	740.9M	4.3B	5.5B	6.3B	6.6B
Reconciled Depreciation	635.6M	643.0M	643.9M	929.6M	1.0B	778.7M

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

Other Information on Investing in Sichuan Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Sichuan Historical Income Statement

About Sichuan Income Statement Analysis

Sichuan Hebang Income Statement Chart

Total Revenue

Net Income

Sichuan Hebang income statement Correlations

Sichuan Hebang Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Sichuan Hebang income statement Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Sichuan Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income	+ 1.0	Income Before Tax
Tax Provision	+ 1.0	Net Income From Continuing Ops
Income Before Tax	+ 0.99	Operating Income
Net Income	+ 0.99	Operating Income
Net Income From Continuing Ops	+ 0.99	Operating Income
Net Income From Continuing Ops	+ 0.99	Income Before Tax

Minority Interest	- 0.94	Ebit
Minority Interest	- 0.93	Income Tax Expense
Ebitda	- 0.91	Minority Interest
Minority Interest	- 0.9	Total Operating Expenses
Reconciled Depreciation	- 0.87	Minority Interest
Total Other Income Expense Net	- 0.87	Total Operating Expenses